Effects of bepotastine and fexofenadine on histamine-induced flare, wheal and itch

International Archives of Allergy and Immunology

Volumn 158, Issue 2, 2012, Pages 191-195

  Tanizaki, Hideaki ^a   Ikoma, Akihiko ^b   Fukuoka, Miyuki ^a   Miyachi, Yoshiki ^a   Kabashima, Kenji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bepotastine besilate; Fexofenadine hydrochloride; Histamine; Pruritus; Urticaria

Indexed keywords

BEPOTASTINE; FEXOFENADINE; HISTAMINE; PLACEBO;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DRUG EFFECT; FEMALE; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PRURITUS; SKIN BLOOD FLOW; SKIN IRRITATION; TREATMENT RESPONSE; URTICARIA;

ADULT; FEMALE; HISTAMINE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; MALE; PIPERIDINES; PRURITUS; PYRIDINES; SKIN; TERFENADINE; URTICARIA;

EID: 84856199989     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000330663     Document Type: Article

References (17)

1. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gimenez-Arnau A, Grattan CE, Kapp A, Merk HF, Rogala B, Saini S, Sanchez-Borges M, Schmid-Grendelmeier P, Schunemann H, Staubach P, Vena GA, Wedi B, Maurer M: EAACI/GA(2) LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64: 1417-1426.
2. Zuberbier T, Ifflander J, Semmler C, Henz BM: Acute urticaria: clinical aspects and therapeutic responsiveness. Acta Derm Venereol 1996; 76: 295-297. (Pubitemid 26247000)
3. Nakahara T, Urabe K, Moroi Y, Morita K, Furue M: Bepotastine besilate rapidly inhibits mite-antigen induced immediate reactions in atopic dermatitis. J Dermatol Sci 2003; 32: 237-238. (Pubitemid 37162699)
4. Tokura Y, Kobayashi M, Kabashima K: Epidermal chemokines and modulation by antihistamines, antibiotics and antifungals. Exp Dermatol 2008; 17: 81-90.
5. Kobayashi M, Kabashima K, Nakamura M, Tokura Y: Downmodulatory effects of the antihistaminic drug bepotastine on cytokine/chemokine production and CD54 expression in human keratinocytes. Skin Pharmacol Physiol 2009; 22: 45-48.
6. Moniaga CS, Egawa G, Doi H, Miyachi Y, Kabashima K: Histamine modulates the responsiveness of keratinocytes to IL-17 and TNF-alpha through the H 1 -receptor. J Dermatol Sci 2011; 61: 79-81.
7. Otsuka A, Honda T, Doi H, Miyachi Y, Kabashima K: An H 1 -histamine receptor antagonist decreases serum IL-31 levels in patients with atopic dermatitis. Br J Dermatol 2011; 164: 455-456.
8. Sugita K, Kobayashi M, Mori T, Kabashima K, Nakamura M, Tokura Y: Antihistaminic drug olopatadine downmodulates CCL17/TARC production by keratinocytes and Langerhans cells. J Dermatol 2009; 36: 654-657.
9. Kobayashi M, Yoshiki R, Sakabe J, Kabashima K, Nakamura M, Tokura Y: Expression of Toll-like receptor 2, NOD2 and dectin-1 and stimulatory effects of their ligands and histamine in normal human keratinocytes. Br J Dermatol 2009; 160: 297-304.
10. Clough GF, Bennett AR, Church MK: Effects of H 1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging. Br J Dermatol 1998; 138: 806-814. (Pubitemid 28231521)
11. Ishibashi Y, Kawashima M, Harada S, Suzuki Y: Phase I study of antiallergic agent, TAU-284 (bepotastine besilate): study of inhibitory effect on intradermal reaction of histamine. J Clin Therap Med 1997; 13: 53-63.
12. Physician Desk Reference: allegra (fexofenadine) capsules, prescribing information as of November 2000. Montvale, Medical Economics Company. http://www.Pdr.Net.
13. Tanizaki H, Kambe N, Nakamura Y, Tanaka A, Matsuda H, Miyachi Y: Oral administration of bepotastine besilate suppressed scratching behavior of atopic dermatitis model Nc/Nga mice. Int Arch Allergy Immunol 2008; 145: 277-282. (Pubitemid 351416708)
14. Kato M, Nishida A, Aga Y, Kita J, Kudo Y, Narita H, Endo T: Pharmacokinetic and pharmacodynamic evaluation of central effect of the novel antiallergic agent bepastine besilate. Arzneimittelforschung 1997; 47: 1116-1124. (Pubitemid 27451895)
15. Russell T, Stoltz M, Weir S: Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers. Clin Pharmacol Ther 1998; 64: 612-621. (Pubitemid 29011381)
16. Schmelz M, Michael K, Weidner C, Schmidt R, Torebjork HE, Handwerker HO: Which nerve fibers mediate the axon reflex flare in human skin? Neuroreport 2000; 11: 645-648. (Pubitemid 30120491)
17. Andoh T, Kuraishi Y: Suppression by bepotastine besilate of substance P-induced itchassociated responses through the inhibition of the leukotriene B 4 action in mice. Eur J Pharmacol 2006; 547: 59-64. (Pubitemid 44373903)